BPC-157 (BPC-157) by Guangdong ZetaPharmax Co., Ltd: new bulk ingredient listing
BPC-157 (BPC-157) by Guangdong ZetaPharmax Co., Ltd: new bulk ingredient listing. Dated 85 days ago, it serves as a historical benchmark. Score 15/100. As of 2026-11-03, from U.S. FDA National Drug Code (NDC) Directory via openFDA.
Data as of · Compiled by Zalwin from U.S. FDA National Drug Code (NDC) Directory via openFDA
Free preview: all 9 published fields of this record are shown below. Locked: 313 related FdaNdcDirectoryPulse records and the 5-column CSV export.
| Field | Value |
|---|---|
| Generic name | BPC-157 |
| NDC | 84795-006 |
| Labeler | Guangdong ZetaPharmax Co., Ltd |
| Product type | BULK INGREDIENT |
| Approval pathway | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| Dosage form | POWDER |
| Active ingredients | BPC-157 1 g/g |
| Marketing start | 2026-08-11 |
| Package configurations | 1 |
| Peer records CSV (314 records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch BPC-157 (BPC-157) by Guangdong ZetaPharmax Co., Ltd
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Unlock BPC-157 (BPC-157) by Guangdong ZetaPharmax Co. + all 314 records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Product · Labeler · Pathway · Form · Listed · official source URL
- Source agency: U.S. FDA National Drug Code (NDC) Directory via openFDA
- Record date: 2026-08-11
- Data refreshed: 2026-11-03
- Refunds on request within 14 days
Top FdaNdcDirectoryPulse records (BULK INGREDIENT first): Ensitrelvir Fumaric Acid (Ensitrelvir Fumaric Acid) by Shion · alirocumab (alirocumab) by SAMSUNG BIOLOGICS Co., Ltd. · Dapoxetine HCl (Dapoxetine HCl) by AX Pharmaceutical Corp · LEFLUNOMIDE (LEFLUNOMIDE) by MAEDA INC · Slu PP 915 (Slu PP 915) by ETERNAL WEALTH (CHINA) LIMITED · Browse all by state and category →
LIVE PUBLIC DATA Source: U.S. FDA National Drug Code (NDC) Directory via openFDA · Last refreshed: Tue, 03 Nov 2026 18:09:00 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
Peer benchmark and outreach value: BPC-157 (BPC-157) by Guangdong ZetaPharmax Co., Ltd and 314 BULK INGREDIENT peers
- BULK INGREDIENT FdaNdcDirectoryPulse records like this one: 314
- Timing: Low: older than 30 days
- Estimated pipeline if you contact every BULK INGREDIENT peer: $62,800 (peers × rate × deal size; an estimate from your assumptions, not a forecast)
15 / 100 Launch Signal Score
What is the FdaNdcDirectoryPulse record for BPC-157 (BPC-157) by Guangdong ZetaPharmax Co., Ltd?
BPC-157 by Guangdong ZetaPharmax Co., Ltd: new bulk ingredient listing (BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING) starting 2026-08-11.
How does BPC-157 (BPC-157) by Guangdong ZetaPharmax Co., Ltd compare to other FdaNdcDirectoryPulse records?
It is 85 days old; check the official source for later updates before acting. Its Launch Signal Score of 15/100 is modest; treat it as background rather than a priority.
BPC-157 (BPC-157) by Guangdong ZetaPharmax Co., Ltd vs. top 3 peers
| Organization | Location | Record date |
|---|---|---|
| BPC-157 (BPC-157) by Guangdong ZetaPharmax Co., Ltd | BULK INGREDIENT | 2026-08-11 |
| Ifosfamide | HUMAN PRESCRIPTION DRUG | 2026-09-04 |
| Rifadin | HUMAN PRESCRIPTION DRUG | 2026-08-03 |
| Oxygen | HUMAN PRESCRIPTION DRUG | 2026-07-15 |
Related records
- Ifosfamide
- Rifadin
- Oxygen
- Water (Water) by Siegfried Hameln GmbH: new drug for further processing listing
- Donanemab (Donanemab) by BSP Pharmaceuticals S.p.A.: new drug for further processing listing
- apitegromab (apitegromab) by Catalent Pharma Solutions, LLC: new drug for further processing listing
- zilganersen (zilganersen) by Patheon Italia S.p.A.: new drug for further processing listing
- teduglutide (teduglutide) by Patheon Italia S.p.A.: new drug for further processing listing
- rusfertide (rusfertide) by Patheon Italia S.p.A.: new drug for further processing listing
- rusfertide (rusfertide) by Patheon Italia S.p.A.: new drug for further processing listing
- rusfertide (rusfertide) by Patheon Italia S.p.A.: new drug for further processing listing
- rusfertide (rusfertide) by Patheon Italia S.p.A.: new drug for further processing listing
How to monitor BPC-157 (BPC-157) by Guangdong ZetaPharmax Co., Ltd and peer other records
Get new FdaNdcDirectoryPulse records like BPC-157 (BPC-157) by Guangdong ZetaPharmax Co., Ltd by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get new listings in your categories
FdaNdcDirectoryPulse emails new drug listings matching your pathway and product type.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
Listing data comes from the FDA NDC directory via openFDA; a listing is not an FDA approval or endorsement and may be updated or withdrawn. Informational only; not medical advice.